Ben Foster

US Equity Strategist
Earnings • Growth • Momentum
Tracking the next market leaders
Markets never sleep.

[Ben Foster @BenFosterFin]

Friday could be an interesting rotation day.

Nasdaq futures are under pressure while Dow futures are holding up better.

That tells me investors may be taking some profits in high-beta tech and looking for relatively steadier areas.

If that gap widens after the open, watch for a possible rotation trade.

Not necessarily bearish.

Just different money moving around.

#StockMarket #WallStreet #Investing

[Ben Foster @BenFosterFin]

AI power demand is another theme I'm keeping on my radar.

You can build all the GPUs you want.

They still need electricity.

The bigger AI gets, the bigger the infrastructure problem becomes.

#NVDA #AIStocks #StockMarket

[Ben Foster @BenFosterFin]

If Nvidia crushes earnings but yields jump, don't be surprised if tech still struggles.

Great earnings + bad rates can still equal a messy tape.

Macro matters.
#NVDA #AIStocks #StockMarket

[Ben Foster @BenFosterFin]

The best opportunities don't announce themselves. They quietly build while everyone is watching something else.

That was the case with $LWLG.

📈 Today's gain: +16.57%
💰 Current price: $7.95 (+$1.13)
Most traders notice a stock after it starts making headlines.

I'm more interested in the phase before that—when the technology is gaining validation, commercial milestones are getting closer, and the market hasn't fully priced in the potential.

$LWLG is another reminder that the biggest moves often begin with a story that's still being overlooked.

Every stock won't be a winner, and that's not the goal.

The goal is to consistently identify high-quality setups where the upside is worth the risk—then let the market do the rest.

If you enjoy finding emerging opportunities before they become crowded trades, you're in the right place.

Follow for more research, market insights, and stock ideas that focus on what could happen next, not just what already happened.

#NASDAQ #AI #Photonics #Semiconductors #GrowthStocks #StockMarket #WallStreet

[Ben Foster @BenFosterFin]

$LWLG: Key Points Company Focus: Dedicated to the development and commercialization of electro-optic polymers (EO polymers, Perkinamine platform) for use in high-speed optical modulators in AI data centers and silicon photonics applications, which can increase data transmission speeds and reduce power consumption.
Current Status: Still in the early stages of commercialization, with extremely low revenue (approximately $237,000 for full-year 2025 and approximately $29,000 for Q1 2026) and ongoing losses; however, cash reserves of approximately $75 million to $100 million are sufficient to sustain the company through 2027 and beyond.
Customer Progress: Four Fortune Global 500 customers have entered Stage 3 prototyping; an additional 1–2 Tier-1 customers are expected by the end of 2026; the goal is to enter high-volume production (Stage 4) in 2027 and secure material supply/licensing agreements.
Validation Milestones: Marvell’s acquisition of Polariton (which relies on LWLG polymers) further validates the technology path; PDK integration is underway with foundries such as Tower Semiconductor and GlobalFoundries.

Geopolitical Risks Affecting Supply: The $LWLG platform is entirely rare-earth-free, with the entire manufacturing process completed in Colorado, USA, and a 100% domestic supply chain.
This makes it relatively immune to the impact of Chinese rare-earth export restrictions and other geopolitical tensions on traditional materials (such as lithium niobate thin films and indium phosphide). The company emphasizes that maintaining control over production, quality, and innovation domestically reduces the risk of external supply disruptions and creates a competitive advantage.

Investment Rationale: Essential Demand for AI Optical Interconnects: As hyperscale data centers evolve toward 1.6T/3.2T and even higher speeds, demand for low-power, high-bandwidth modulators is exploding, and polymer solutions offer both performance and cost potential.
Technology and Ecosystem Validation: Progress in reliability testing (Telcordia GR-468), the implementation of PDKs by foundries, and the Marvell-Polariton transaction provide external validation.
Commercialization Inflection Point Approaching: The transition from prototyping to mass production is the key catalyst; once the shift from Stage 3 to Stage 4 is successful, revenue is expected to shift from NRE/material sales to a scaled licensing model.
Capital and Time Window: Sufficient cash reserves cover the critical execution period, avoiding significant near-term dilution pressure.

Key Focus Areas: Customer Stage progress and the timing of naming/mass production contract finalization.
Revenue, cash burn, and milestone updates in quarterly earnings reports (next one expected around mid-August).
Whether foundry capacity constraints are slowing customer progress.
Intensifying competition (from other photonic materials/modulator solutions) and technical execution risks.
High volatility and dilution risk (if additional financing is required in the future).
Sustainability of macro AI capital spending.

Target Range: $10–11
#StockMarket #AI #Nasdaq #Investing #TechStocks #Photonics #Bullish

[Ben Foster @BenFosterFin]

$LWLG: Key Points Company Focus: Dedicated to the development and commercialization of electro-optic polymers (EO polymers, Perkinamine platform) for use in high-speed optical modulators in AI data centers and silicon photonics applications, which can increase data transmission speeds and reduce power consumption.
Current Status: Still in the early stages of commercialization, with extremely low revenue (approximately $237,000 for full-year 2025 and approximately $29,000 for Q1 2026) and ongoing losses; however, cash reserves of approximately $75 million to $100 million are sufficient to sustain the company through 2027 and beyond.
Customer Progress: Four Fortune Global 500 customers have entered Stage 3 prototyping; an additional 1–2 Tier-1 customers are expected by the end of 2026; the goal is to enter high-volume production (Stage 4) in 2027 and secure material supply/licensing agreements.
Validation Milestones: Marvell’s acquisition of Polariton (which relies on LWLG polymers) further validates the technology path; PDK integration is underway with foundries such as Tower Semiconductor and GlobalFoundries.

Geopolitical Risks Affecting Supply: The $LWLG platform is entirely rare-earth-free, with the entire manufacturing process completed in Colorado, USA, and a 100% domestic supply chain.
This makes it relatively immune to the impact of Chinese rare-earth export restrictions and other geopolitical tensions on traditional materials (such as lithium niobate thin films and indium phosphide). The company emphasizes that maintaining control over production, quality, and innovation domestically reduces the risk of external supply disruptions and creates a competitive advantage.

Investment Rationale: Essential Demand for AI Optical Interconnects: As hyperscale data centers evolve toward 1.6T/3.2T and even higher speeds, demand for low-power, high-bandwidth modulators is exploding, and polymer solutions offer both performance and cost potential.
Technology and Ecosystem Validation: Progress in reliability testing (Telcordia GR-468), the implementation of PDKs by foundries, and the Marvell-Polariton transaction provide external validation.
Commercialization Inflection Point Approaching: The transition from prototyping to mass production is the key catalyst; once the shift from Stage 3 to Stage 4 is successful, revenue is expected to shift from NRE/material sales to a scaled licensing model.
Capital and Time Window: Sufficient cash reserves cover the critical execution period, avoiding significant near-term dilution pressure.

Key Focus Areas: Customer Stage progress and the timing of naming/mass production contract finalization.
Revenue, cash burn, and milestone updates in quarterly earnings reports (next one expected around mid-August).
Whether foundry capacity constraints are slowing customer progress.
Intensifying competition (from other photonic materials/modulator solutions) and technical execution risks.
High volatility and dilution risk (if additional financing is required in the future).
Sustainability of macro AI capital spending.

Target Range: $10–11
#StockMarket #AI #Nasdaq #Investing #TechStocks #Photonics #Bullish

[Ben Foster @BenFosterFin]

Every big winner starts with one clear decision.
Today I’m locking eyes on $NVDA — the undisputed AI king still offering growth at a reasonable multiple. Pairing it with $MU for the memory boom no one can ignore, and $AMZN for the long-term cloud + AI flywheel.
Stay disciplined, stay curious, and let the market reward patience. Your future self will thank you. Let’s build wealth together 💪
#StockMarket #AI #Nasdaq #Investing #TechStocks #Earnings #Bullish

[Ben Foster @BenFosterFin]

Some people are always waiting for confirmation signals.
I prefer to spot opportunities before they become obvious.

Today’s recommendation, $CDNA, is a perfect example of this.

📈 **Current Gain: +9.49%
💰 Stock Price: $47.86 (+$4.15)

By the time a stock becomes a hot topic on social media, most of the easy profit opportunities have already been snapped up.

I spend my time researching catalysts, studying charts, and filtering out the noise—so when I share an investment idea, it’s because I believe the risk-reward ratio is worth paying attention to.

Today’s rally certainly won’t be the last.

If you’re looking for stock opportunities worth paying close attention to before they go viral, follow me. The market rewards those who prepare in advance, not those who lag behind and follow the crowd.

The next breakout is already on my watchlist. 🚀

#Nasdaq #StockMarket #Biotech #GrowthStocks #Investing #WallStreet #Trading

[Ben Foster @BenFosterFin]

$CDNA: A leading U.S. company in post-transplant molecular diagnostics, focused on helping physicians monitor the risk of transplant rejection and reduce the need for invasive biopsies through non-invasive dd-cfDNA (donor-derived cell-free DNA) and gene expression testing. The industry operates in the high-growth sectors of precision medicine and liquid biopsy: Solid organ transplant patients require lifelong monitoring, and transplant volumes in the U.S. and globally are steadily rising; combined with demand for monitoring in specialized oncology areas (such as HPV-related solid tumors) and minimal residual disease (MRD) monitoring, management estimates the total addressable market (TAM) has exceeded $12 billion. Clarification of Medicare coverage policies has further expanded reimbursement opportunities, and the industry has entered an acceleration phase characterized by “evidence-driven progress and reimbursement implementation.”

Product and Certification Highlights: Core products include AlloSure (dd-cfDNA monitoring for kidney, heart, and lung transplants), AlloMap (gene expression profiling for heart transplants), and HistoMap.
New Development: The acquisition of Naveris was completed in July 2026, introducing NavDx (HPV-associated solid tumor testing) and securing ADLT certification, thereby expanding into specialized oncology.
Approvals and Milestones: Medicare’s Local Coverage Determination (LCD) for molecular testing in solid organ transplantation has been finalized, explicitly covering AlloSure and AlloMap for monitoring purposes; multiple clinical data sets continue to be published, supporting the expansion of indications and use cases.
Support Services: Patient and digital solutions (workflow software, patient support) enhance customer retention and repeat purchases.

Core Investment Logic: Dual Growth in Penetration, Volume, and Price: Transplant monitoring still has significant room for market penetration, with expanding use in both “for-cause” and surveillance testing; higher revenue per test combined with volume growth drives high-margin testing services.
Platform Expansion: Divestment of non-core businesses and the acquisition of Naveris are replicating the “vertical molecular testing + clinical evidence + workflow” model in oncology and cell therapy, opening up a larger total addressable market (TAM).
Confirmed Profitability Inflection Point: High revenue growth combined with operational efficiency has led to a significant improvement in adjusted EBITDA and enhanced cash generation capabilities.
Policy and Evidence Moat: The implementation of Medicare coverage reduces reimbursement uncertainty, while ongoing clinical data solidifies the company’s position as the standard of care.

Target Price: $45–55
#NVDA #MU #SPCX #MSFT #AMZN #AAPL #TSLA

[Ben Foster @BenFosterFin]

$AVLND +17% Many members followed my latest trading guidance—and profits are now firmly in their pockets! Missed this opportunity? Don't worry. If you're interested in joining, click on my profile to add my WhatsApp number. I share carefully selected stock recommendations like this every day.
#BRAG #USStocks #Stock #StockMarket #StockTrading #SPY #QQQ #NVDA #Tesla

[Ben Foster @BenFosterFin]

Most people only start talking about a stock *after* it already exploded. Inside my private group, members get the full setup *before* the move happens. Today’s alert:
$A *** Expected intraday volatility: 10%–40% Inside the group, I share: • Entry zones • Stop-loss levels • Real-time sell alerts • Position management updates I don’t post random hype calls publicly. I focus on complete trade execution and risk control. If you want to stay ahead of the crowd instead of chasing stocks after they run, add me on WhatsApp through the link in my profile. I’ll send you the full setup directly.
#Stocks #StockMarket #StockTrading #AIStocks #NVDA #Semiconductors #PLTR #FedWatch #SmallCaps

[Ben Foster @BenFosterFin]

Most people only start talking about a stock *after* it already exploded. Inside my private group, members get the full setup *before* the move happens. Today’s alert:
$A *** Expected intraday volatility: 10%–40% Inside the group, I share: • Entry zones • Stop-loss levels • Real-time sell alerts • Position management updates I don’t post random hype calls publicly. I focus on complete trade execution and risk control. If you want to stay ahead of the crowd instead of chasing stocks after they run, add me on WhatsApp through the link in my profile. I’ll send you the full setup directly.
#Stocks #StockMarket #StockTrading #AIStocks #NVDA #Semiconductors #PLTR #FedWatch #SmallCaps

[Ben Foster @BenFosterFin]

$CDNA: A leading U.S. company in post-transplant molecular diagnostics, focused on helping physicians monitor the risk of transplant rejection and reduce the need for invasive biopsies through non-invasive dd-cfDNA (donor-derived cell-free DNA) and gene expression testing. The industry operates in the high-growth sectors of precision medicine and liquid biopsy: Solid organ transplant patients require lifelong monitoring, and transplant volumes in the U.S. and globally are steadily rising; combined with demand for monitoring in specialized oncology areas (such as HPV-related solid tumors) and minimal residual disease (MRD) monitoring, management estimates the total addressable market (TAM) has exceeded $12 billion. Clarification of Medicare coverage policies has further expanded reimbursement opportunities, and the industry has entered an acceleration phase characterized by “evidence-driven progress and reimbursement implementation.”

Product and Certification Highlights: Core products include AlloSure (dd-cfDNA monitoring for kidney, heart, and lung transplants), AlloMap (gene expression profiling for heart transplants), and HistoMap.
New Development: The acquisition of Naveris was completed in July 2026, introducing NavDx (HPV-associated solid tumor testing) and securing ADLT certification, thereby expanding into specialized oncology.
Approvals and Milestones: Medicare’s Local Coverage Determination (LCD) for molecular testing in solid organ transplantation has been finalized, explicitly covering AlloSure and AlloMap for monitoring purposes; multiple clinical data sets continue to be published, supporting the expansion of indications and use cases.
Support Services: Patient and digital solutions (workflow software, patient support) enhance customer retention and repeat purchases.

Core Investment Logic: Dual Growth in Penetration, Volume, and Price: Transplant monitoring still has significant room for market penetration, with expanding use in both “for-cause” and surveillance testing; higher revenue per test combined with volume growth drives high-margin testing services.
Platform Expansion: Divestment of non-core businesses and the acquisition of Naveris are replicating the “vertical molecular testing + clinical evidence + workflow” model in oncology and cell therapy, opening up a larger total addressable market (TAM).
Confirmed Profitability Inflection Point: High revenue growth combined with operational efficiency has led to a significant improvement in adjusted EBITDA and enhanced cash generation capabilities.
Policy and Evidence Moat: The implementation of Medicare coverage reduces reimbursement uncertainty, while ongoing clinical data solidifies the company’s position as the standard of care.

Target Price: $45–55
#NVDA #MU #SPCX #MSFT #AMZN #AAPL #TSLA

[Ben Foster @BenFosterFin]

Amazon shares had surged recently on strong cloud (AWS) growth and AI optimism, helping lift broader tech sentiment into the new week.

#Amazon #AMZN #AWS #CloudComputing #AI

[Ben Foster @BenFosterFin]

While the market digests mega-cap results, these leaders are showing relative strength. $MSFT exploded higher on accelerating Azure growth and strong AI guidance. Follow-through buying after a big earnings gap is classic. $NVDA remains the AI chip king. Data-center demand stays robust — any risk-on open or sector bounce can push it higher fast. Cloud powerhouse + AI hardware king. Clean momentum stories. Which one are you eyeing? Like & share if you want more daily ideas
#AI #Microsoft #Nvidia #CloudComputing #Semiconductors #StockMarket #Earnings

[Ben Foster @BenFosterFin]

Looking ahead into early August, focus shifts to the upcoming jobs report, continued earnings, Nvidia’s later report, and whether AI spending concerns fully ease or if higher yields and oil keep markets choppy.
#NVDA #MSFT #MU #AVGO #TSLA #AMZN #GOOGL

[Ben Foster @BenFosterFin]

Today’s recommended stock, $DAAQ , closed up 0.12%, perfectly aligning with the chart pattern we shared earlier. A steady, controlled move. Not a hint of panic. Just a clean, crisp execution of the technical move, ultimately resulting in a green flag. This is why serious traders always keep their eyes on the charts instead of chasing market noise.
Making accurate judgments time and time again. If you want to see more of these low-pressure, high-clarity setups in your feed every day, you know what to do. Follow me.
Don’t miss out on those truly effective strategies anymore.
#StockMarket #Nasdaq #Investing #Trading #Stocks #WallStreet #Finance

[Ben Foster @BenFosterFin]

$DAAQ:
Old Glory Holding Company / Old Glory Bank (an FDIC-insured bank in Oklahoma, founded in 1903 and restructured in 2022). A digital-first, full-service bank that emphasizes privacy, security, freedom, and support for the 2nd Amendment community, serving approximately 85,000 retail and commercial accounts across all 50 U.S. states. Deposits have grown rapidly from an initial level of approximately $10 million to around $270 million (recent Call Report shows approximately $269 million in deposits and total assets of approximately $277 million); revenue comes from low-cost deposits, fee income, and consumer/commercial banking products (including loans, SBA loans, etc.); plans to further integrate cryptocurrency into everyday banking services

Macroeconomic Context
The trend toward integrating cryptocurrency and digital banking continues; concerns about “debanking” are driving demand for banks that prioritize privacy, are 2A-friendly, and offer crypto integration; FDIC-insured digital-first banks are expanding; the rebound in U.S. tech and semiconductor stocks, along with AI-related sentiment, indirectly supports the fintech narrative. The overall macroeconomic environment provides support for digital asset-related SPACs, but interest rates and regulation remain variables.

August 14, 2026: Special shareholders’ meeting votes to approve the business merger with Old Glory Bank (originally postponed from July 31)—this decision will have the greatest impact on whether the merger can proceed.
Regulatory/shareholder approvals and closing (targeted for the first half of the year or later, depending on the vote and conditions).
Following the merger, the company will be renamed OGB Financial Company and plans to list on the Nasdaq (ticker: OGB).
The board plans to appoint individuals with crypto and financial backgrounds, including Peter Ort and former Grayscale CEO Michael Sonnenshein.
The redemption period has ended; remaining trust funds will be used for post-merger operations.

Competitive Moat — Platform + Differentiation
Digital-first mobile/online platform + nationwide coverage + U.S.-based customer service; core differentiators include “cancel culture protection,” a commitment to privacy (no indiscriminate data sharing), positioning as a 2A/patriotic community, and plans for crypto integration. More flexible than traditional big banks, yet offers the advantages of FDIC insurance and a banking license compared to pure-play fintech firms. Rapid customer acquisition and low-cost deposits create potential for economies of scale.

Target Price: $10–$15

#Microsoft #Micron #SKHynix #SanDisk #NVIDIA #Amazon #SpaceX

[Ben Foster @BenFosterFin]

$AMCX +16% Many members followed my latest trading guidance—and profits are now firmly in their pockets! Missed this opportunity? Don't worry. If you're interested in joining, click on my profile to add my WhatsApp number. I share carefully selected stock recommendations like this every day.
#BRAG #USStocks #Stock #StockMarket #StockTrading #SPY #QQQ #NVDA #Tesla #AIStocks

[Ben Foster @BenFosterFin]

Most people only start talking about a stock *after* it already exploded. Inside my private group, members get the full setup *before* the move happens. Today’s alert:
$A*** Expected intraday volatility: 10%–40% Inside the group, I share: • Entry zones • Stop-loss levels • Real-time sell alerts • Position management updates I don’t post random hype calls publicly. I focus on complete trade execution and risk control. If you want to stay ahead of the crowd instead of chasing stocks after they run, add me on WhatsApp through the link in my profile. I’ll send you the full setup directly.
#Stocks #StockMarket #StockTrading #AIStocks #NVDA #Semiconductors #PLTR #FedWatch #SmallCaps

[Ben Foster @BenFosterFin]

Most people only start talking about a stock *after* it already exploded. Inside my private group, members get the full setup *before* the move happens. Today’s alert:
$A*** Expected intraday volatility: 10%–40% Inside the group, I share: • Entry zones • Stop-loss levels • Real-time sell alerts • Position management updates I don’t post random hype calls publicly. I focus on complete trade execution and risk control. If you want to stay ahead of the crowd instead of chasing stocks after they run, add me on WhatsApp through the link in my profile. I’ll send you the full setup directly.
#Stocks #StockMarket #StockTrading #AIStocks #NVDA #Semiconductors #PLTR #FedWatch #SmallCaps

[Ben Foster @BenFosterFin]

$DAAQ:
Old Glory Holding Company / Old Glory Bank (an FDIC-insured bank in Oklahoma, founded in 1903 and restructured in 2022). A digital-first, full-service bank that emphasizes privacy, security, freedom, and support for the 2nd Amendment community, serving approximately 85,000 retail and commercial accounts across all 50 U.S. states. Deposits have grown rapidly from an initial level of approximately $10 million to around $270 million (recent Call Report shows approximately $269 million in deposits and total assets of approximately $277 million); revenue comes from low-cost deposits, fee income, and consumer/commercial banking products (including loans, SBA loans, etc.); plans to further integrate cryptocurrency into everyday banking services

Macroeconomic Context
The trend toward integrating cryptocurrency and digital banking continues; concerns about “debanking” are driving demand for banks that prioritize privacy, are 2A-friendly, and offer crypto integration; FDIC-insured digital-first banks are expanding; the rebound in U.S. tech and semiconductor stocks, along with AI-related sentiment, indirectly supports the fintech narrative. The overall macroeconomic environment provides support for digital asset-related SPACs, but interest rates and regulation remain variables.

August 14, 2026: Special shareholders’ meeting votes to approve the business merger with Old Glory Bank (originally postponed from July 31)—this decision will have the greatest impact on whether the merger can proceed.
Regulatory/shareholder approvals and closing (targeted for the first half of the year or later, depending on the vote and conditions).
Following the merger, the company will be renamed OGB Financial Company and plans to list on the Nasdaq (ticker: OGB).
The board plans to appoint individuals with crypto and financial backgrounds, including Peter Ort and former Grayscale CEO Michael Sonnenshein.
The redemption period has ended; remaining trust funds will be used for post-merger operations.

Competitive Moat — Platform + Differentiation
Digital-first mobile/online platform + nationwide coverage + U.S.-based customer service; core differentiators include “cancel culture protection,” a commitment to privacy (no indiscriminate data sharing), positioning as a 2A/patriotic community, and plans for crypto integration. More flexible than traditional big banks, yet offers the advantages of FDIC insurance and a banking license compared to pure-play fintech firms. Rapid customer acquisition and low-cost deposits create potential for economies of scale.

Target Price: $10–$15

#Microsoft #Micron #SKHynix #SanDisk #NVIDIA #Amazon #SpaceX

[Ben Foster @BenFosterFin]

After a volatile week, including the Federal Reserve's decision to keep interest rates unchanged and a midweek sell-off, U.S. stocks rebounded strongly before the close on Thursday and strengthened further in the futures market on Friday. Long-term Treasury yields remained near multi-year highs, while oil prices retreated somewhat as shipping activity in the Strait of Hormuz resumed. Earnings reports from major tech companies continued to dominate market sentiment as the market entered the final trading day of July.

#Amazon #Apple #AWS #iPhone #AIWinner #EarningsReport #MajorTechCompanies

[Ben Foster @BenFosterFin]

Solid software and tech gainers: $INTU up about 6%, $ADBE rising roughly 5.7%, and $WDAY advancing over 5%. $INTU continues to show resilience in tax and small-business software, $ADBE benefits from creative cloud and AI features, while $WDAY maintains enterprise HR and finance software demand. These are higher-quality names more suitable for ongoing observation.
#MSFT #META #NVDA #AAPL #FedDecision #ChipStocks #OilPrices

[Ben Foster @BenFosterFin]

$AXTI +22% Many members followed my latest trading guidance—and profits are now firmly in their pockets! Missed this opportunity? Don't worry. If you're interested in joining, click on my profile to add my WhatsApp number. I share carefully selected stock recommendations like this every day.
#BRAG #USStocks #Stock #StockMarket #StockTrading #SPY #QQQ #NVDA #Tesla #AIStocks

[Ben Foster @BenFosterFin]

Most people only start talking about a stock *after* it already exploded. Inside my private group, members get the full setup *before* the move happens. Today’s alert:
$A *** Expected intraday volatility: 10%–40% Inside the group, I share: • Entry zones • Stop-loss levels • Real-time sell alerts • Position management updates I don’t post random hype calls publicly. I focus on complete trade execution and risk control. If you want to stay ahead of the crowd instead of chasing stocks after they run, add me on WhatsApp through the link in my profile. I’ll send you the full setup directly.
#Stocks #StockMarket #StockTrading #AIStocks #NVDA #Semiconductors #PLTR #FedWatch #SmallCaps